FDA NDC Directory · JSON-LD · Markdown

VEOPOZ

NDC 61755-014 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namePozelimab
Labeler / ManufacturerRegeneron Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA761339
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsPOZELIMAB (200 mg/mL)
Marketing started20230818
Package count1

External sources

Source: openFDA. Public-domain (CC0).